Ikarian Capital’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-289,538
| Closed | -$5.7M | – | 121 |
|
|
2025
Q1 | $5.7M | Sell |
289,538
-105,000
| -27% | -$2.07M | 0.7% | 19 |
|
|
2024
Q4 | $8.88M | Sell |
394,538
-105,028
| -21% | -$2.36M | 1.21% | 7 |
|
|
2024
Q3 | $12.8M | Sell |
499,566
-86,986
| -15% | -$2.22M | 1.78% | 3 |
|
|
2024
Q2 | $13.7M | Buy |
+586,552
| New | +$13.7M | 2.39% | 6 |
|